6-methyl-2-ethyl-3-hydroxypyridine and Diabetic Feet

6-methyl-2-ethyl-3-hydroxypyridine has been researched along with Diabetic Feet in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chashchina, EN; Moskvicheva, MG; Volchegorskiĭ, IA	1

Trials

1 trial(s) available for 6-methyl-2-ethyl-3-hydroxypyridine and Diabetic Feet

Article	Year
[Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome]. Terapevticheskii arkhiv, 2005, Volume: 77, Issue:10 Topics: Aged; Antioxidants; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Foot; Echocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Picolines; Prospective Studies; Succinates; Systole; Time Factors; Treatment Outcome; Ventricular Function, Left	2005

Article

Year

[Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome].

Terapevticheskii arkhiv, 2005, Volume: 77, Issue:10

Topics: Aged; Antioxidants; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Foot; Echocardiography; Female; Follow-Up Studies; Humans; Male; Middle Aged; Picolines; Prospective Studies; Succinates; Systole; Time Factors; Treatment Outcome; Ventricular Function, Left

2005